I'm LongbridgeAI, I can summarize articles.Greenwich LifeSciences CEO and CFO Snehal Patel purchased 3,600 common shares on the open market for approximately $47,005. The average purchase price was about $13.06 per share. Following this transaction, Patel's direct holdings increased to 5,607,702 common shares. This information was reported via EDGAR.
- Greenwich Lifesciences CEO and CFO Snehal Patel reported open-market purchases totaling 3,600 common shares. * Average purchase price was about USD 13.06 per share. * Patel’s direct holding rose to 5,607,702 common shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Greenwich Lifesciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-034675), on July 27, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here